{"slideshow_credits": null, "snippet": "An experimental drug appears to preserve and possibly even improve the ability of boys with Duchenne muscular dystrophy to walk, but there are caveats.", "abstract": "Experimental drug eteplirsen, made by Sarepta Therapeutics, preserves and even improves the walking ability of boys with Duchenne muscular dystrophy in a clinical trial; it remains unclear how long the drug's effects will last or if safety issues will arise.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/10/04/business/drug-shows-promise-in-treating-type-of-muscular-dystrophy.html", "lead_paragraph": "An experimental drug appears to preserve and possibly even improve the ability of boys with Duchenne muscular dystrophy to walk, but there are caveats.", "headline": {"main": "Drug Shows Promise in Treating a Type of Muscular Dystrophy in Boys", "print_headline": "Drug Shows Promise in Treating a Type of Muscular Dystrophy in Boys"}, "_id": "507c49e695e998af71184f88", "word_count": "839", "multimedia": [{"height": 75, "url": "images/2012/10/04/business/Drug/Drug-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2012/10/04/business/Drug/Drug-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-10-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Muscular Dystrophy", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Sarepta Therapeutics Inc.", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}